Teladoc Health, Inc. (TDOC)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $bn | 1 | 2 | 2 | 3 | 3 | 3 | 2 | 2 |
| Operating profit | $bn | -0 | -0 | ||||||
| Net profit | $bn | -0 | -0 | -14 | -0 | -1 | -0 | -0 | -0 |
| EPS reported | $ | -1.14 | -0.99 | ||||||
| Operating cashflow per share | $ | 1.67 | 1.45 | ||||||
| Capex per share | $ | 0.05 | 0.20 | ||||||
| FCF per share | $ | 1.62 | 1.25 | ||||||
| Free cash flow | $bn | 0 | 0 | ||||||
| Net debt | $bn | 0 | 0 | ||||||
| Book value equity | $bn | 1 | 1 | ||||||
| Book value per share | $ | 7.86 | 7.28 | ||||||
| Number of shares | m | 176.22 | 180.08 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | - | - | ||||||
| P/B LTM | x | 0.89 | 0.94 | ||||||
| P/S LTM | x | 0.49 | 0.50 | ||||||
| P/FCF LTM | x | 4.32 | 5.49 | ||||||
| EV/EBITDA LTM | x | 10.13 | -21.36 | ||||||
| EV/Sales LTM | x | 0.59 | 0.62 | ||||||
| Earnings Yield LTM | % | -16.24% | -13.86% | ||||||
| FCF Yield | % | +23.14% | +18.21% | ||||||
| Quality | |||||||||
| ROE | % | -14.46% | -13.08% | ||||||
| ROIC | % | -8.26% | -7.11% | ||||||
| Operating margin | % | -10.39% | -6.98% | ||||||
| Gross margin | % | +69.50% | +73.53% | ||||||
| FCF/Sales | % | +11.28% | +9.02% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | -1.54% | -3.12% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | +0.91% | -20.58% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.27 | 0.22 | ||||||
| Net Debt/EBITDA | x | 1.76 | -3.60 | ||||||
| EBIT/Net interest | x | -13.34 | -8.71 | ||||||
| Net debt/market cap | % | +81.55% | +77.16% | ||||||
| Net debt/Equity | x | 0.16 | 0.18 | ||||||
| Gross debt/equity | x | 0.75 | 0.79 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free